Company attributes
B2X
CEO
Founder
Legal Name
Avammune Therapeutics Inc.
Number of Employees (Ranges)
11 – 50
Investors
Founded Date
2017
Total Funding Amount (USD)
12,000,000
Latest Funding Round Date
May 7, 2025
Latest Funding Type
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
12,000,000
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
